Vaishali Pharma
add_icon

Vaishali Pharma

6.33
-0.17
(-2.62%)
Market Cap
82.58 Cr
PE Ratio
-162.50
Volume
2,72,266.00
Day High - Low
6.74 - 6.20
52W High-Low
15.24 - 6.40
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
82.58 Cr
EPS
0.06
PE Ratio
-162.50
PB Ratio
1.26
Book Value
5.16
EBITDA
3.30
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
1.26
Debt to Equity
0.24
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,825.30
#1 4,37,950.61
39.98
#1 54,729.00
9.71
#1 10,980
16.07
70.29
6,282.00
1,66,767.36
67.99
9,712.00
18.67
2,191
-1.02
49.00
4,446.00
1,50,472.84
65.98
11,539.40
6.99
1,911
26.24
68.79
1,319.00
1,10,087.74
20.03
33,741.20
16.73
5,725
-15.28
59.78
2,357.30
1,07,681.18
22.96
22,909.50
13.74
3,306
#1 37.44
67.87
1,324.30
1,06,973.22
23.70
28,409.50
7.12
5,291
-57.18
43.23
916.90
92,261.59
#1 18.46
23,511.00
18.55
4,615
-0.32
52.66
2,207.90
91,143.23
51.36
12,744.20
#1 20.90
2,007
7.65
55.18
1,311.90
76,195.36
21.74
32,345.60
9.43
3,484
7.59
70.43
5,444.00
65,091.19
27.32
13,458.30
3.70
2,216
1.90
43.98
Growth Rate
Revenue Growth
15.74 %
Net Income Growth
14.29 %
Cash Flow Change
-2,327.16 %
ROE
-25.00 %
ROCE
-29.23 %
EBITDA Margin (Avg.)
-10.31 %

Quarterly Financial Results

Quarterly Financials
Jun 2025
Sept 2025
Dec 2025
Revenue
25
34
26
Expenses
22
32
23
EBITDA
2
2
2
Operating Profit %
6 %
4 %
6 %
Depreciation
0
0
0
Interest
0
0
1
Profit Before Tax
2
2
2
Tax
1
1
1
Net Profit
1
1
1
EPS in ₹
0.10
0.09
0.10

Balance Sheet

Balance Sheet
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
45
64
69
66
86
82
79
80
110
Fixed Assets
1
1
1
2
1
1
2
2
2
Current Assets
40
59
63
61
81
76
73
75
105
Capital Work in Progress
0
0
0
0
0
1
1
1
0
Investments
0
0
0
0
0
0
0
0
0
Other Assets
43
62
67
64
84
80
76
77
107
Total Equity & Liabilities
45
64
69
66
86
82
79
80
110
Current Liabilities
37
41
43
40
59
52
32
33
40
Non Current Liabilities
4
3
5
4
4
3
6
4
5
Total Equity
4
21
21
21
22
26
41
43
65
Reserve & Surplus
1
14
15
11
12
16
30
32
39
Share Capital
3
7
7
11
11
11
11
11
26

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
-0
0
0
0
0
1
-0
1
0
Investing Activities
2
3
1
1
-0
0
-0
-1
0
1
-0
Operating Activities
-4
5
1
-10
4
3
2
1
1
1
-18
Financing Activities
2
-8
-1
9
-4
-3
-2
0
-2
-1
19

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
May 2024
Jun 2024
Jul 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
63.81 %
59.21 %
56.31 %
56.31 %
26.74 %
26.74 %
26.74 %
26.74 %
26.74 %
26.74 %
26.62 %
26.62 %
26.32 %
24.87 %
26.32 %
31.61 %
26.32 %
26.32 %
26.32 %
26.32 %
26.32 %
31.61 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
32.30 %
33.44 %
39.72 %
39.82 %
65.28 %
62.35 %
58.58 %
62.85 %
64.91 %
65.97 %
62.00 %
60.94 %
62.93 %
66.66 %
66.11 %
62.17 %
64.98 %
64.93 %
65.24 %
65.88 %
67.25 %
62.75 %
Others
3.89 %
7.36 %
3.98 %
3.87 %
7.98 %
10.91 %
14.68 %
10.41 %
8.34 %
7.29 %
11.38 %
12.45 %
10.74 %
8.46 %
7.57 %
6.22 %
8.70 %
8.75 %
8.44 %
7.80 %
6.43 %
5.65 %
No of Share Holders
6,558
10,306
10,822
10,211
9,611
9,390
8,347
8,954
9,374
9,573
9,983
9,181
9,390
10,296
9,479
9,479
18,983
27,546
28,874
28,682
27,752
27,752

Technical Indicators

RSI(14)
Neutral
20.76
ATR(14)
Less Volatile
0.41
STOCH(9,6)
Oversold
9.91
STOCH RSI(14)
Oversold
11.11
MACD(12,26)
Bearish
-0.07
ADX(14)
Strong Trend
37.31
UO(9)
Bearish
30.72
ROC(12)
Downtrend And Accelerating
-15.91
WillR(14)
Oversold
-93.75